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Toxoplasma gondii resides within an intracellular parasitophorous vacuole (PV) selectively permeable to small molecules. Gold et al. identify GRA17 and GRA23 as secreted Toxoplasma proteins that mediate the passage of small molecules between the host cytoplasm and PV, providing a molecular explanation for how these vacuoleresiding parasites access host nutrients.
INTRODUCTION
Protozoan parasites in the phylum Apicomplexa present a global human and veterinary health problem. Toxoplasma gondii, which causes toxoplasmosis, can infect a wide range of warm-blooded animals including humans and is a particular challenge to immune-compromised individuals such as AIDS patients and fetuses of infected mothers. Apicomplexan parasites spend the majority of their life cycle within host cells and have evolved diverse strategies to survive in this niche. Many, like Toxoplasma and Plasmodium, reside within a nonfusogenic parasitophorous vacuole (PV). The PV membrane (PVM) is the physical interface between PV-residing parasites and their host cells during intracellular growth, remaining intact until parasite egress. The PV protects parasites from being sensed by the host cell, but it is also a potential barrier to the scavenging of nutrients from the host and to parasite effectors accessing the host.
Apicomplexan parasites depend on host cells for many essential nutrients. For instance, Toxoplasma is auxotrophic for small molecules including amino acids like tryptophan and arginine, purines, and sterols (reviewed in Coppens, 2014) . Some, like sterols, are actively scavenged from the host cell to the PV through sterol transporters on the PVM (Ehrenman et al., 2010) . Transporters for small metabolites have been identified on the Toxoplasma plasma membrane but not on the PVM (Landfear, 2011) . The Toxoplasma, Plasmodium, and Eimeria PVMs are selectively permeable, allowing passive, charge-independent diffusion of small molecules up to 1,300-1,900 Da into the PV, presumably through pore-like molecules on the PVM (Desai and Rosenberg, 1997; Schwab et al., 1994; Werner-Meier and Entzeroth, 1997) . This is the putative mechanism by which the parasite within the PV gains access to host metabolites or effluxes toxic metabolic byproducts like lactate into the host cell. The molecular identity of the pores that grant this PVM permeability is unknown.
Toxoplasma partially circumvents the PVM barrier by secreting proteins into the host cell before and during invasion before formation of the PV from secretory organelles that include rhoptries and dense granules. Secreted effectors play a critically important role in Toxoplasma pathogenesis, modulating host signaling and creating a hospitable environment in the PV (reviewed in Hunter and Sibley, 2012; Kemp et al., 2013) . Unlike the invasion-secreted rhoptry proteins (ROPs), dense granule proteins (GRAs) are also secreted post-invasion (Karsten et al., 1998) .
Plasmodium exports proteins beyond its PVM into the erythrocyte cytosol. EXP2 is the putative protein-conducting pore of the Plasmodium translocon for exported proteins (PTEX) complex that mediates the essential export of secreted proteins containing a Plasmodium export element (PEXEL) sequence motif (de Koning-Ward et al., 2009 ). There are also PEXEL-independent mechanisms of protein export (Grü ring et al., 2012; Siau et al., 2014) that utilize the same PTEX machinery (Beck et al., 2014; Elsworth et al., 2014) . In Toxoplasma, post-invasion protein export into the host cell has only been reported for GRA16 and GRA24 (Bougdour et al., 2013; Braun et al., 2013) . Most characterized Toxoplasma GRA proteins are involved in organizing the structure and environment of the PV or associated with the PVM, but others such as GRA15, GRA16, and GRA24 play a role in modulating host cell signaling, suggesting that there may be more GRA proteins trafficked beyond the PVM after invasion (Bougdour et al., 2013; Mercier et al., 2005; Rosowski et al., 2011) .
We sought to investigate the molecular interaction between the Toxoplasma PV and the host cell by studying a PVM-localized GRA protein with homology to Plasmodium EXP2.
RESULTS

GRA17
Is a Secreted GRA Protein Required for Normal PV Morphology Since EXP2 has been implicated in forming a molecular-translocation channel in the P. falciparum PVM, we searched for homologs in the Toxoplasma genome and found two genes encoding proteins with predicted signal peptides: the uncharacterized TGGT1_222170 and TgGRA23 (TGGT1_297880), an identified GRA gene of unknown function (Masatani et al., 2013) . TGGT1_222170 and TgGRA23 share 30% amino acid sequence similarity with each other and 26% and 22% similarity with PfEXP2, respectively ( Figure S1A ). Homologs of these proteins, including Sarcocystis muris DG32 (Freyer et al., 1999) , were identified only in Apicomplexa that replicate within a PV (Table 1) . Except for Plasmodium spp. EXP2, none of these genes have been functionally characterized, but due to its similarity to GRA23, we provisionally named TGGT1_222170, ''GRA17.'' There is only one gene similar to TgGRA17 or TgGRA23 found in Eimeria spp. and Plasmodium spp., but we found two distinct homologs in the genomes of other sequenced PV-residing Apicomplexa that are grouped in the family Sarcocystidae (Table 1; Figure S1B ). We found that GRA17 and GRA23 are conserved proteins with high gene transcription levels across a global range of Toxoplasma strains (Melo et al., 2013; Minot et al., 2012) .
Besides strongly predicted a helices, GRA17 and GRA23 lack sequence motifs that suggest a functional role. To characterize them, we individually disrupted the GRA17 and GRA23 genes and we complemented the DGRA17 strain with either HA-tagged GRA17 or Toxoplasma-codon-optimized P. falciparum EXP2 transgenes that we will refer to as ''DGRA17+GRA17-HA'' and ''DGRA17+PfEXP2-HA'' ( Figures S2A-S2E ). The DGRA17 strain was also complemented with GRA23-HA-FLAG (HF) expressed from either the putative gra23 promoter ''DGRA17+GRA23-HF low '' or from the strong gra1 promoter ''DGRA17+GRA23-HF high ''; the differing expression levels in these strains were verified by western blot ( Figure S2F ). We infected human foreskin fibroblasts (HFFs) with tachyzoites (the fast-replicating stage of Toxoplasma), fixed, and analyzed the sample by deconvolution immunofluorescence (IF) microscopy. The DGRA17+GRA17-HA strain was used for many co-staining experiments as it does not express GFP, and the GRA17-HA localization was invariant across all the strains (data not shown). We observed that GRA17-HA is intra-vacuolar and is associated with the PVM and possibly the tubulo-vesicular network (TVN) based on its partial co-localization with GRA7 (a PVM and TVN marker) and GRA4 (a TVN marker) especially around the periphery of the PV ( Figure 1A ). GRA23 has previously been characterized as a PVMlocalized GRA (Masatani et al., 2013) , and to observe its relative co-localization with GRA17, we generated a strain that co-expresses GRA17-V5 and GRA23-HF (the tachyzoites express GFP) and observed substantial co-localization around the PVM (Figures 1A, bottom panel, and S2G) ; however, the localization of GRA17-HA appeared localized to discrete foci relative to the more continuous pattern of GRA23-HF around the PVM. PfEXP2-HA localized to the PVM in the DGRA17 strain, and the localization of GRA23-HF was unaffected by the absence of GRA17 in the DGRA17+GRA23-HF low strain ( Figure S2H ). We confirmed that GRA17 is a GRA by observing partial co-localization of GRA17 and GRA7 in extracellular tachyzoites ( Figure S2I ). We raised a specific antibody against GRA17 that detected a 19 kDa band that is absent in the DGRA17 strain ( Figure S3A , lanes 1-4). We tested GRA17 association with the PVM by fractionating HFFs infected with WT+GRA17-HA by ultracentrifugation and extracting a membrane-enriched fraction with either PBS or sodium carbonate. Sodium carbonate treatment extracts peripherally attached proteins such as GRA1, but more tightly membrane-associated proteins like GRA7 remain in the insoluble fraction (Neudeck et al., 2002; Sibley et al., 1995) . We found that in contrast to GRA1, GRA17 was only minimally extracted by sodium carbonate and that the majority remained in the insoluble fraction ( Figure 1B) . Thus, the majority of GRA17 is tightly asso- The WT+GRA17-V5/GRA23-HA-FLAG also expresses cytosolic GFP. The fluorescent images represent a single deconvoluted focal slice. Bright-field images were taken with differential interference contrast (DIC) microscopy (scale bar = 10 mm). (B) HFFs were infected with WT+GRA17-HA tachyzoites for 24 hr and mechanically lysed, and a membrane-enriched fraction was treated with either PBS or sodium carbonate, centrifuged to obtain pelleted (P) and soluble (S) fractions, and subjected to SDS-PAGE. The fractions were western blotted as indicated. (C) HFFs were infected with the indicated strains for 36 hr and imaged live by phase contrast microscopy (scale bar = 25 mm). ciated with the PVM. A similar fractionation pattern for GRA23 has been reported (Masatani et al., 2013) .
We observed that a significant portion of PVs in the DGRA17 strain were grossly enlarged relative to the number of parasites in the PV, whereas the DGRA23 PVs are similar to wild-type (WT) (Figure 1C) . Furthermore, the DGRA17-complemented strains, DGRA17+GRA17-HA and DGRA17+PfEXP2-HA, completely rescued this aberrant morphology. We were unable to generate a DGRA17/DGRA23 strain, but we were able to delete the GRA23 gene from the DGRA17+GRA17-HA strain, which has low GRA17 expression ( Figure S3A , lanes 2 and 8). We observed that this DGRA17/DGRA23+GRA17-HA strain mimics the aberrant PV morphology of the DGRA17 strain ( Figure 1C ), providing evidence of functional overlap between GRA17 and GRA23. Furthermore, the DGRA17 strain complemented with high (but not lower) expression of GRA23-HF partially suppressed this phenotype, with infrequent enlarged vacuoles observed ( Figure 1C ).
We examined whether there were other genes involved in a compensatory role with the DGRA17 strain by sequencing the total mRNA from bone-marrow-derived mouse macrophages 4 hr post-infection with WT, DGRA17, DGRA23, and DGRA17+GRA17-HA strains and mapping the sequences to the Toxoplasma genome. As previously observed, GRA17 expression in the DGRA17+GRA17-HA strain was 2.5-fold less compared to WT despite its ability to functionally rescue the DGRA17 strain ( Figure S3B ) (GEO: GSE65980). GRA23 expression levels in the DGRA17 strain were 1.8-fold increased over WT levels, and GRA17 levels were not increased in the DGRA17 strain ( Figure S3B ). We found five additional, uncharacterized putative signal peptide-containing proteins that were uniquely upregulated in the DGRA17 strain (Table S2 ).
GRA17 Is Involved in the Movement of Small Molecules between the Host and PV
Since PfEXP2 can rescue a DGRA17 phenotype, we wondered whether GRA17 or GRA23 plays a role in protein export beyond the PVM. The GRA proteins GRA16 and GRA24 localize to the host nucleus with increasing intensity over the time of infection, peaking at 20 hr, indicating that they are exported across the PVM after the PV has been formed (Bougdour et al., 2013; Braun et al., 2013) . We tagged the endogenous copy of GRA24 with HA-FLAG (HF) in the WT, DGRA17, and DGRA23 strains. We also transiently transformed GRA16-HF into WT, DGRA17, and DGRA23 extracellular tachyzoites with which we immediately infected HFFs. We then fixed the infected cells at early and late time points post-infection. Across all strains we observed a temporal increase from low to high levels of GRA16-HF and GRA24-HF staining in the host nucleus (Figures 2A and S3C ). Thus, neither Figure S3D ) and averaged across three experimental replicates (error bars are ± SD).
GRA17 nor GRA23 are individually required for GRA16 and GRA24 export beyond the PVM. While GRA17 and GRA23 do not appear to affect protein transport across the PVM, we asked if they function as a pore for small molecules and metabolites. We used the properties of the vital dye 5-(and-6)-carboxy-2 0 ,7 0 -dichlorofluorescein diacetate (CDCFDA) to test this hypothesis. CDCFDA is membrane permeable and non-fluorescent until it enters living cells, where intracellular esterases convert it into the fluorescent, membrane-impermeable 5-(and-6)-carboxy-2 0 ,7 0 -dichlorofluorescein (CDCF). The molecular weight of the CDCF fluorophore (445.2 Da) is less than the established size-exclusion limit of the Toxoplasma PVM (Schwab et al., 1994) , so we predicted that it should passively enter into the PV through the PVM but be unable to permeate through the tachyzoite plasma membrane (Schwab et al., 1994) . We infected HFFs with the WT, DGRA17, DGRA17+GRA17-HA, DGRA23, DGRA17+PfEXP2-HA, DGRA17/DGRA23+GRA17-HA, and DGRA17+GRA23-HF low/high strains for 24 hr and then added a pulse of CDCFDA to the cell culture medium before washing away the dye and subsequently imaging the living cells. As predicted, we observed CDCF-fluorescence intensity equivalent to the host cytosol within nearly all the PVs of the WT, DGRA17+GRA17-HA, DGRA17+PfEXP2-HA, and DGRA23 strains but excluded from the tachyzoites themselves ( Figure 2B , white arrows). By contrast, 36% of the PVs in the DGRA17 strain had equivalent intra-PV CDCF-fluorescence compared to the host cytosol (p = 4 3 10 À8 to WT; Figure 2B , red arrow and right panel), suggesting a role for GRA17 involving the passage of small molecules into the PV. We observed a similar phenotype for the DGRA17/DGRA23+GRA17-HA strain, with CDCFfluorescence in 51% of PVs (p = 0.002 to WT and no statistical difference to DGRA17; Figure 2B , right panel). In contrast to the DGRA17+GRA23-HF low strain, which was similar to the DGRA17 strain (45% intra-PV CDCF-fluorescence; p = 0.002 from WT), we observed a partial rescue of dye transfer with the DGRA17+GRA23-HF high strain with CDCF fluorescence in 73% of PVs that was statistically distinct from the DGRA17 strain (p = 0.01; Figure 2B ), further suggesting a synergistic role for GRA23 in small molecule permeability. Since we observed PVs of varying permeability within the same host cell ( Figure 2B , DGRA17), the GRA17-mediated effect on PVM permeability to the small molecule fluorophore is PV autonomous and independent of host intracellular fluorophore concentration. We confirmed this phenotype by introducing the membraneimpermeable dyes lucifer yellow (522 Da) or Dextran (3,000 Da)-Alexa-488 into infected cells by the technique of scrapeloading (McNeil et al., 1984) . Since cellular dye uptake varies around the scrape, there was a large degree of heterogeneity of both intracellular and intra-PV dye intensities. We scored the intra-PV dye intensity relative to its host cell dye intensity as ''present,'' ''absent,'' or ''intermediate'' (Figure S3D ). We found that the scrape-loaded lucifer yellow results were similar to the CDCFDA results: in contrast to >90% of WT, DGRA17+ GRA17-HA, and DGRA23 PVs, only 22% of DGRA17 PVs were scored as having fluorescence fully equivalent to their host cells ( Figure 2C ). When the larger dextran (3,000 Da) dye was scrapeloaded into infected cells, we found that most of the PVs of both WT and DGRA17 failed to uptake the dye, consistent with the established Toxoplasma PVM size-exclusion limit (Schwab et al., 1994) . These results provide further evidence that PfEXP2 can rescue DGRA17 phenotypes and for functional overlap between GRA17 and GRA23.
The Absence of GRA17 Results in Highly Dynamic, Unstable PV We found that fixatives altered the appearance and numbers of the enlarged, aberrant DGRA17 PVs (data not shown), so we imaged the DGRA17 strain live over an extended time period post-infection to observe the dynamics of these PVs. Nearly all of the PVs we observed by live imaging appeared enlarged at some point during the experimental time course. We also observed many enlarged PVs ''collapsing,'' where the tachyzoites within them turn opaque and cease to divide. As an example, we present a multiple infected host cell where all but one PV collapses over a 5:30 hr time course ( Figure 3A ; Movie S1). The remaining intact PV within this cell remained enlarged and continued to divide, ultimately egressing from the cell at 62:00 hr (Movie S2). We have also observed PV collapse in singly infected cells ( Figure S4A ). Furthermore, we observed dynamic alteration of the size and shape of the vacuoles as exemplified by a PV that becomes grossly enlarged to the size of the entire host cell before ultimately egressing ( Figure S4B ; Movies S3 and S4). Since the tachyzoites within these enlarged PVs divide normally and we regularly observe egress, it indicates that they are viable.
In concordance with the PV collapse, we observed that DGRA17 tachyzoites grew more slowly than WT tachyzoites. We measured this effect by quantifying the mean area of plaques formed in HFF monolayers by infection with the DGRA17 and DGRA23 strains relative to WT. These assays measure the overall growth of the parasites in vitro. We found that DGRA17 formed plaques that were 53% the size of the WT strain (p < 0.0001; Figures 3B and S5A) , and the DGRA17+ GRA17-HA strain fully rescued this growth defect. The DGRA23 strain formed plaques that were slightly smaller than the WT strain, but this effect was not significant (p = 0.21; Figures 3B  and S5A ). In contrast to the smaller plaques made by the DGRA17 strain, we observed that a strain that overexpresses GRA17-HA (WT+GRA17-HA; Figure S3A , lanes 9 and 10) formed plaques that were 67% larger than WT (p < 0.0001; Figures 3B and S5A) , implying that excess GRA17 can accelerate growth of the parasite. The collapsed PVs with non-dividing tachyzoites suggest a basis for the slow growth of the DGRA17 strain in vitro.
GRA17 and GRA23 Affect the In Vivo Growth and Virulence of Toxoplasma
We examined whether the effects of GRA17 on overall Toxoplasma proliferation in vitro would manifest in vivo. We infected CD-1 outbred mice intraperitoneally (i.p.) with 100 tachyzoites of the WT, DGRA17, DGRA17+GRA17-HA, and DGRA23 strains. We also infected an additional cohort with 1,000 tachyzoites of the DGRA17 strain. None of the mice infected with the WT, DGRA23, and DGRA17+GRA17-HA strains survived beyond 12 days post-infection ( Figure 4A ), consistent with the reported hyper-virulence of the type I genetic background of our strains (LD 100 = $1 tachyzoite). By contrast, all of the mice infected with either the low or high dose of the DGRA17 tachyzoites survived. All of these mice were seropositive and were resistant to subsequent challenge with 10,000 WT (type I) tachyzoites ( Figure 4A, arrow) . Subsequently, we infected cohorts of CD-1 mice with 100 tachyzoites each of the DGRA17, DGRA17+GRA17-HA, DGRA17+PfEXP2-HA, and DGRA17/DGRA23+GRA17-HA strains and monitored both body weight and survival. We found that none of the mice infected with DGRA17+GRA17-HA or DGRA17+PfEXP2-HA survived past 12 days post-infection, whereas all of the mice infected with the DGRA17 or DGRA17/DGRA23+GRA17-HA strains survived the duration of the experiment ( Figure 4B , top). In contrast to the mice infected with DGRA17 parasites, those infected with DGRA17/DGRA23+GRA17-HA experienced a significant drop in body weight and deterioration in body condition (e.g., hunched stance and ruffled fur) during the course of infection before recovering fully by 30 days post-infection ( Figure 4B, bottom) . Thus, PfEXP2 can rescue the loss of GRA17 in vivo, and the deletion of GRA23 with low GRA17 expression renders Toxoplasma avirulent. Since the type I strain is hyper-virulent in mice, we tested the accelerated growth in vivo by overexpressing GRA17 in the far less virulent type III strain (LD 50 = 10 5 tachyzoites), which also accelerated its in vitro growth ( Figure S5B ). We infected BALB/ c mice with this strain and a WT (type III) strain. We found that all the infected mice survived, but the mice infected with type III+GRA17-HA had a higher parasite burden ( Figure S5C ), lost more weight ( Figure S5D ), had a worse body condition (e.g., hunched posture and ruffled coat), and had a higher brain tissue cyst count in some but not all of this cohort ( Figure S5E ).
GRA17 and GRA23 Are Synergistically Required for Growth
We were able to detect DGRA23 phenotypes only in the background of significantly reduced GRA17 expression, and the overexpression of GRA23-HF in the DGRA17 background was able to partially rescue DGRA17 phenotypes, suggesting GRA17 and GRA23 operate synergistically. While we were able to generate multiple, independent clonal tachyzoite iso- (B) Confluent monolayers of HFFs were infected with 100 tachyzoites of each indicated strain for 4 days. For every experiment, the area of at least 30 plaques from each strain was measured ( Figure S5A ), and the mean area was normalized to WT. Each bar of the graph represents an average of means across experimental replicates (n = 8 for all conditions except for DGRA17+ GRA17-HA, where n = 3). Error bars represent ± SD, and paired two-tailed t tests were performed comparing each condition to WT to assess statistical significance (*** p < 0.0001).
lates of DGRA17/DGRA23+GRA17-HA, we could not generate a DGRA17/ DGRA23 strain in parallel by multiple methods. In order to determine whether a DGRA17/DGRA23 strain is viable, we used the CRISPR gene disruption technology developed for Toxoplasma (Shen et al., 2014; Sidik et al., 2014) . We chose target strains where GRA17-HA is the only species of GRA17 present so we could follow its fate by IF microscopy. As a test, we co-transformed the DGRA17/DGRA23+GRA17-HA strain with Cas9-3xFLAG, a guide RNA (gRNA) to target protospacer sequences early within the GRA17 coding sequence as well as a double-stranded oligonucleotide donor template containing a nonsense mutation near the predicted Cas9-cleavage site. We cotransformed donor templates with our gRNAs, since our target strain background is DKu80, which eliminates non-homologous endjoining in favor of homologous recombination (Fox et al., 2009) . We used three different gRNA/donor template pairings, fixed at 24 hr and 48 hr, and observed these gRNAs led to similar GRA17-HA loss relative to no loss with a non-specific gRNA ( Figures 5A, top panel, and S6 ).
After transformation of both the DGRA17/DGRA23+GRA17-HA and DGRA17+GRA17-HA strains with Cas9-3xFLAG, a GRA17-specific gRNA/donor ([residues 29-36]/donor template [Leu32stop]) and subsequent infection of HFFs, we fixed infected cells early to compare the initial loss of GRA17-HA signal in the population (24 hr) to late, when the parasites will form plaques in the host cell monolayer (120 hr). Both target strains were transformed at an equivalent rate as measured by Cas9-3xFLAG detection ($27%-28%; Figure 5B , top panel). We also found that DGRA17+GRA17-HA and DGRA17/DGRA23+GRA17-HA had comparable loss of GRA17-HA signal at 24 hr post-infection (23% and 26% out of the total population, respectively; Figure 5B , top panel). By contrast, we found that 6.6% (of 584 total plaques scored) of the DGRA17+GRA17-HA plaques were GRA17-HA negative at 120 hr post-infection compared to 0% (of 934 plaques scored) in the DGRA17/DGRA23+GRA17-HA strain (p < 0.0001; Figures 5A, bottom panel, and 5B, bottom panel). In parallel, we serially diluted the transformants into HFFs to isolate tachyzoite clones: 2/20 clones from the DGRA17+ GRA17-HA strain were GRA17-HA negative compared to 0/ 120 clones from the DGRA17/DGRA23+GRA17-HA strain. Taken together, our results strongly indicate that GRA17 and GRA23 are synergistically required for Toxoplasma growth.
GRA17 and GRA23 Alter the Membrane Conductance of Xenopus Oocytes
We expressed GRA17 and GRA23 in Xenopus oocytes to see if they can alter membrane permeability consistent with the insertion of large, relatively non-selective pores into the cell membranes. The expression of such a non-selective pore makes several experimentally testable predictions. The first is that expression will be detrimental to cells, resulting in significant cell death due to loss of cell contents and inability to maintain volume homeostasis. When varying levels of GRA17 and GRA23 cRNAs were injected into Xenopus oocytes, a dosedependent increase in cell lysis was observed relative to waterinjected cells or to GRA15 cRNA, a GRA protein that localizes to the PVM (Rosowski et al., 2011) but which is not predicted to affect membrane permeability ( Figure 6A ). HA-tagged versions of GRA17, GRA23, and GRA15 were detected in total membrane fractions isolated from cRNA-injected oocytes ( Figures S7A and  S7B) , and GRA17 and GRA23 were also observed localized to the oocyte plasma membrane in fixed histology sections (Figure S7C) . The second prediction is that increased membrane permeability through expression of putative non-selective pores would cause a depolarizing shift in membrane resting potential prior to cell lysis, and GRA17 and GRA23 both demonstrated this shift relative to water-or GRA15-injected oocytes (Figure 6B) . Finally, the current to voltage relationship of the net membrane current for a large non-selective, constitutively open pore should result in an increased linear current-voltage relationship ( Figure 6C ), a depolarization of the reversal potential (''V rev ''; Figure 6D , top panel), and an increased conductance (''G''; Figure 6D , bottom panel) for GRA17 and GRA23 relative to water-or GRA15-injected oocytes, which we observed. The results of these exogenous expression studies are strongly consistent with the hypothesis that GRA17 and GRA23 can form non-selective high-conductance pores when exogenously expressed in cell membranes. We injected a separate batch of Xenopus oocytes with PfEXP2-HA cRNA and, as with the Toxoplasma GRAs, found that it was present in total membrane and cytosolic fractions ( Figure S7D ). Relative to GRA17 and GRA23, PfEXP2 cRNA-injected oocytes had a more modest decrease in survival (73% compared to 93% of water-injected oocytes; Figure S7E ). There was no statistically significant difference between PfEXP2 cRNA-injected oocytes and waterinjected control resting membrane potential (RMP) ( Figure S7F) ; however, the control oocytes had a significantly depolarized RMP compared to the previous batches of oocytes used for the Toxoplasma GRAs ( Figure 6B) , making direct comparison difficult. We did observe a statistically significant increased conductance (G) change in PfEXP2 cRNA-injected oocytes (Figures S7G and S7H) , which is consistent with PfEXP2 forming a large membrane pore. Further work is needed to characterize the role of PfEXP2 as a membrane pore.
DISCUSSION
Intracellular pathogens that reside within vacuoles face a challenge of scavenging nutrients and modulating the host cell beyond their vacuole membrane. The existence of putative pores providing selective permeability to small molecules in the Toxoplasma and Plasmodium PVMs had been described (Desai and Rosenberg, 1997; Schwab et al., 1994) , and now we have provided a molecular basis for this phenomenon in any Apicomplexa. The flow of small molecules between the host cytosol and PV plays a critical role in tachyzoite growth and survival, and its reduction may result in either restriction to nutrients or the inability of toxic metabolic byproducts to efflux (A) Cohorts of five female CD-1 mice (aged 6-8 weeks) were each infected with 100 tachyzoites (one additional cohort was infected with 1,000 tachyzoites of DGRA17) i.p. with each type I (RH) strain and survival was monitored. At day 30, the surviving DGRA17 mice from the 100 tachyzoites infection were re-infected with 10 4 WT tachyzoites, and survival was monitored (arrow).
(B) Infection of mice was carried out as above, and survival was monitored for 34 days post-infection (top panel). The mice were weighed throughout the infection and plotted as an average of the change in body weight for each cohort, where 100% body weight is the day before infection (bottom panel).
Error bars indicate +SD, and single asterisks indicate p < 0.05 statistical significance assessed at that time point compared to DGRA17 by a Student's t test.
out of the PV. Overexpressing GRA17 leads to more rapid growth, suggesting that nutrients scavenged by Toxoplasma via GRA17 may be limiting factors for normal growth of the parasite. An important question is how the DGRA17 strain remains viable in vitro when it is starved from access to small molecules. A hint as to why some parasites retain viability lies in the aberrant morphology of the DGRA17 PVs. The tachyzoites within the enlarged vacuoles are viable as they replicate and egress. The aberrant PVs may then be the byproduct or consequence of a compensatory mechanism for GRA17 absence. Compensation may include a change in the osmolarity or other structural forces, resulting in PV enlargement. The collapsed PVs may be due to ineffective compensation to reduced access to small molecules or to overcompensation that leads to PV damage. PV collapse, as well as the sensitivity of the enlarged PVs to fixatives, hints at the dynamism and fragility of the DGRA17 PVs and implies a precarious balance of compensatory forces.
A prime candidate for a compensatory molecule is GRA23 based on the body of evidence we have presented. One model is that GRA17 and GRA23 may form a variety of homo-or hetero-multimers whose biophysical properties may differ depending on the composition of the complex. Alternatively, GRA17 and GRA23 may function on the PVM separately, as monomers or otherwise, having partially overlapping but ultimately separable functions. GRA17 and GRA23 may function similarly to a-helical pore-forming molecules like colicins or the pro-apoptotic protein Bax that can exist in either a watersoluble state or as an integral membrane pore that alters permeability (reviewed in Parker and Feil, 2005) . Particularly intriguing are Bax-derived small a-helical peptides that can homo-multimerize within the membrane via a toroidal mechanism that does not require direct protein-protein interactions but instead contains proteins interspersed with lipids (García-Sá ez et al., 2006; Qian et al., 2008) . We have immunoprecipitated both GRA17 and GRA23 from PVM-containing fractions in the cell (data not shown), but we have so far not been able to identify specific interacting proteins. Our mRNA sequencing experiment did identify several other genes encoding putatively secreted protein products that are uniquely upregulated in the DGRA17 strain, but none of these have been functionally characterized to date. Thus, future work is required to define the exact molecular functions of GRA17 and GRA23 as well as identify associated molecular factors.
The observation that Plasmodium EXP2 can rescue DGRA17 phenotypes hints at a possible role of GRA17 or GRA23 in protein export in Toxoplasma. However, GRA16 and GRA24 accumulation in the host nucleus via post-invasion in both the DGRA17 and DGRA23 strains argues against such a role, although GRA17 and GRA23 may have redundant functions in protein export. It will be difficult to distinguish between a potential defect in export in the absence of both proteins versus The percentage of Cas9-3xFLAG-positive vacuoles and GRA17-HA-positive vacuoles out of the total were scored and averaged (top). In total, 750 vacuoles each were scored across three experimental replicates. The percentage of Cas9-3xFLAG-positive plaques and GRA17-HA-positive plaques out of the total were scored and averaged (bottom panel). The number, n, over each bar graph refers to the total number of plaques scored in total for each condition across three experimental replicates. Error bars represent ± SD. Statistical significance was determined using a two-tailed Fisher's exact test comparing the total number of HA-negative vacuoles and plaques for both conditions (***p < 0.0001).
parasites that are dead or dying and thus unable to actively export protein. Ultimately, very little is known about Toxoplasma protein export, and there are currently only two reported exported proteins to test as candidates. Even though Plasmodium EXP2 has not been formally shown to be the translocation pore for protein export, it begs the question of whether it serves a dual role of nutrient pore and protein channel, since EXP2 is the only GRA17-like protein in Plasmodium spp. The aforementioned a-helical pore-forming proteins can form pores big enough for peptides in many cases (Parker and Feil, 2005) , suggesting this dual functionality is feasible. It is possible that the other proteins in the PTEX complex may direct the function of EXP2 from a potential nutrient pore toward a role in protein export.
GRA17 and GRA23 may help elucidate another longstanding question of Toxoplasma biology concerning the sporozoite, the sexually derived stage found in the oocyst. After excystation from the oocyst and invasion of the host cell, the sporozoite forms a unique vacuole (PV1) in which the sporozoite undergoes no replication and ultimately egresses from the PV1 to form a second vacuole (PV2) in the same cell where it completes its conversion to the tachyzoite stage and undergoes replication. Unlike tachyzoite PVs and PV2, the PV1 is impermeable to small molecules and devoid of a subset of GRAs typically associated with PV ultrastructure, suggesting that GRA proteins play a role in this process (Speer et al., 1995) . The PV1 has a strikingly enlarged morphology similar to the DGRA17 PV, and neither GRA17 nor GRA23 are expressed in the oocyst stage (Fritz et al., 2012) , implying the possibility (C) Average membrane currents measured from a holding potential of À90 mV potentials of À120 mV to +50 mV were applied for 2 s. Peak currents from each applied voltage were used to generate an I-V relationship. (D) Average conductance (G, bottom) and the reversal potential (Vrev, top) were computed by fitting the I-V relationship as a straight line. For all above sub-figures, data are shown as the mean ± SE. Confidence levels were calculated using Student's paired t test, where * signifies p < 0.05 when compared to H 2 O-injected oocytes and # signifies p < 0.05 when compared to GRA15-injected oocytes.
that their absence plays a role in the unique properties of the sporozoite PV1.
We believe GRA17 and GRA23 present exciting tools to understand the challenge of how pathogens proliferate within an intracellular vacuole, which is a phenomenon widely conserved in pathogens across evolution.
EXPERIMENTAL PROCEDURES
Reagents 5-(and-6)-carboxy-2 0 ,7 0 -dichlorofluorescein diacetate (C-369) and Dextran 3000-Alexa488 (D34682) were obtained from Life Technologies and lucifer yellow CH dipotassium salt (L0144) from Sigma-Aldrich.
Parasite and Cell Culture and Plaque Size Assays Toxoplasma tachyzoites and HFFs maintenance and plaque size assays were performed as described (Rosowski et al., 2011) .
Transient Transformation and Cas9-Mediated Gene Disruption DNA sequences targeting GRA17 were cloned into the pSS013 Cas9 vector (Sidik et al., 2014) as described in Supplemental Experimental Procedures. Transient transformations of the pSS013 plasmid were performed by co-electroporating 50-100 mg of circular DNA per strain and 25 ml of pre-annealed donor template oligonucleotides (100 mM) into freshly scrapesyringe-lysed tachyzoites, as described in Supplemental Experimental Procedures, and used to infect HFFs immediately. Confluent HFFs on coverslips were infected for fixation at 24 hr, 48 hr, and 120 hr at MOIs of 2, 0.5, and 0.04, respectively; fixed; and processed for IFA. For cloning purposes, transformed parasites were serially diluted into HFFs grown on 96-well plates without selection. Single-plaque wells were replica-passaged for propagation or for IFA with anti-HA antibodies to determine whether GRA17-HA was disrupted.
Microscopy of Fixed Samples
Microscopy was performed with NIS-Elements software (Nikon) and a digital camera (CoolSNAP EZ; Roper Scientific) connected to an inverted fluorescence microscope (eclipse Ti-S; Nikon) and either phase contrast or DIC imaging. Deconvolution imaging was performed using the OptiGrid Structured Light Imaging System (QIOPTIQ Imaging Solutions).
Cell Fractionation
Membrane enriched fractions of infected HFFs were obtained by mechanical lysis and differential centrifugation and treated with 0.1 M sodium carbonate (pH 11) or PBS as described (Sibley et al., 1995) . The resulting pellet and supernatant were subjected to SDS-PAGE and western blotting.
Live Microscopy
HFFs were grown on glass-bottom 24-well plates (Greiner Bio-One) and infected with tachyzoites for 24 hr in growth media. The cells were washed with PBS and replaced with growth media minus phenol red (GMPR) supplemented with 10 mM CDCFDA for 10 min at 37 C. CDCFDA was sequentially diluted into GMPR from a 10 mM DMSO solution. The dye-containing media was removed, and the cells were washed three times with PBS, replaced with GMPR, and were immediately imaged. Scrape-loading experiments were modified from el-Fouly et al. (1987) . Briefly, infected cells were prepared as above on glass bottom 24-well plates. Either 0.5 mM lucifer yellow CH or 0.5 mg/ml Dextran3000-Alexa488 were diluted in GMPR and incubated for 5 min at 37 C. The disposable tip of a 10 ml pipette was used to scape a crisscrossed series of straight lines on the bottom of the well. The cells were washed three times with PBS, replaced with GMPR, and were immediately imaged. For the extended time course experiments, HFFs were infected with the DGRA17 strain. Cells were imaged every 30 min over a 72 hr period using a 403 objective (NA = 0.95) on a Nikon TE2000 inverted microscope equipped with an environmental chamber, Hamamatsu ORCA-ER digital camera, and NIS Elements Imaging Software.
Mouse Survival and Physiology
For mouse infection, infected HFFs were mechanically lysed with 30G needles, washed with PBS, and centrifuged at 99 3 g for 5 min to pellet any intact HFFs. The supernatant was subsequently centrifuged at 582 3 g for 7 min to collect tachyzoites and then diluted in PBS and counted. For the survival assays, 5 female CD-1 mice (age 6-8 weeks, Charles River Laboratories) were infected i.p. with 100 tachyzoites per each strain (plus a cohort of mice was infected with 1,000 tachyzoites of DGRA17). Surviving mice were re-infected i.p. at day 30 post-infection with 10,000 tachyzoites of WT and monitored for survival for an additional 21 days. For all infections, relative parasite MOI was assessed by plaque assays, and all surviving mice were verified to be seropositive for Toxoplasma antigen. Mice below a body condition score of 2 were euthanized and counted as dead in accordance with institutional and federal regulations. All mice were maintained in specific pathogen-free conditions. The MIT Committee on Animal Care approved all protocols (assurance number A-3125-01).
Electrophysiology
Xenopus laevis were cared for according to standards approved by the Institutional Animal Care and Use Committee of the University at Buffalo. The frogs were anesthetized in tricaine (1 g/l; Sigma). Oocytes were digested in 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 HEPES (pH 7.4), 1 mg/ml collagenase, and type I (Sigma) and shaken for 1.5 to 2 hr. Oocytes (stages V-VI) were injected with <50 ng mRNA (Nanoject; Drummond Scientific). cRNA preparation is described in Supplemental Experimental Procedures. Oocytes were voltageclamped at room temperature with a two-electrode clamp (CA-1B; Dagan). Microelectrodes (resistances: 0.5-1.5 MU) were fabricated from 1.5 mm o.d. borosilicate glass tubing (TW150-4; WPI) using a two-stage puller and filled with 3 M KCl. The control extracellular solution (ND96) contained (mM) 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 , and 10 HEPES (pH 7.4). Data were digitized and analyzed using pCLAMP (Axon). Further analysis was performed using Clampfit (Axon), Excel (Microsoft), and Origin (OriginLab). Data were filtered at 2 kHz. 
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